Last filing: Jan 6, 2026. Most recent sale before this period: Jun 14, 2024.
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- Last sale before this period: Jun 14, 2024.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Regeneron Pharmaceuticals (REGN) | Director | Aug 14, 2003 | Jan 6, 2026 |
| Pfizer (PFE) | Former Director | Apr 23, 2004 | Apr 28, 2011 |
Also a director at
Pfizer (PFE) (no filing in the last 18 months)
Recent filings
The last day with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jan 2, 2026, Regeneron Pharmaceuticals: 155 shares granted. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.